For all women who took at least one dose of DSG/EE, a
posttreatment study visit was conducted approximately
3 weeks after the last dose of DSG/EE. In addition,
women who took DSG/EE for at least 3 months, withdrew
from the study and did not initiate a contraceptive method
that regulated or altered the menstrual cycle after the study
discontinued were monitored via telephone monthly for
3 months after the last dose for occurrence of pregnancy and/
or return of menses